BioNTech SE American Depositary Share
Symbol: BNTX (NASDAQ)
102.11
▲ (1.10%) 1.110
Company Description:
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.
Key Stats
- Today's Open: $101.26
- Today's High: $104.451
- Today's Low: $100.856
- Today's Volume: 770.29K
- Yesterday Close: $101
- Yesterday High: $101.85
- Yesterday Low: $99.9
- Yesterday Volume: 915.95K
- Last Min Volume: 196
- Last Min High: $102.11
- Last Min Low: $102.11
- Last Min VWAP: $102.11
Company Profile
- Name: BioNTech SE American Depositary Share
- Website: https://www.biontech.de
- Listed Date: 2019-10-10
- Location: ,
- Market Status: Active
- CIK Number: 0001776985
- SIC Code:
- SIC description:
- Market Cap: $24.28B
- Round Lot: 100
- Outstanding Shares: 240.40M
- Asset Type: ADRC
RECENT FILINGS FOR BNTX
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-08 | 6-K | View |
| 2025-09-08 | F-4/A | View |
| 2025-09-08 | 6-K | View |
| 2025-09-05 | 144 | View |
| 2025-09-05 | 6-K | View |
| 2025-08-27 | 6-K | View |
| 2025-08-15 | 144 | View |
| 2025-08-15 | 144 | View |
| 2025-08-11 | F-4 | View |
| 2025-08-11 | 425 | View |
| 2025-08-11 | 6-K | View |
| 2025-08-08 | 425 | View |
| 2025-08-04 | 6-K | View |
| 2025-08-04 | 6-K | View |
| 2025-07-25 | 6-K | View |
| 2025-07-17 | 6-K | View |
| 2025-06-30 | DRS | View |
| 2025-06-17 | 6-K | View |
| 2025-06-17 | 425 | View |
| 2025-06-17 | 6-K | View |
Latest News on BNTX